Yahoo! Finance: NPHC.OB News

NUTRA PHARMA CORP Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant (EDGAR Online)

Thu, 31 Dec 2009 16:24:38 Etc/GMT

NUTRA PHARMA CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibit (EDGAR Online)

Thu, 24 Dec 2009 19:25:57 Etc/GMT

Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx - Over-the-Counter and Prescription Treatments for Chronic Pain (Business Wire)

Mon, 7 Dec 2009 14:03:00 Etc/GMT

PLANTATION, Fla.----Nutra Pharma Corp. , a biotechnology company that is developing treatments for Adrenomyeloneuropathy , HIV and Multiple Sclerosis , has announced today that it has successfully submitted the final packaging and labeling to the Food and Drug Administration to begin selling Nyloxin OTC, an over-the-counter treatment for moderate to severe chronic pain, and Nyloxin Rx, a prescription treatment for severe chronic pain.

Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain (Business Wire)

Thu, 3 Dec 2009 14:03:00 Etc/GMT

PLANTATION, Fla.----Nutra Pharma Corp. , a biotechnology company that is developing treatments for Adrenomyeloneuropathy , HIV and Multiple Sclerosis , has announced today that it will be hosting an online webinar on December 10, 2009, at 9PM ET to discuss current progress with Cobroxin and Nyloxin Rx, the Company’s treatments for chronic pain.

XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation (Business Wire)

Fri, 27 Nov 2009 14:21:00 Etc/GMT

DELRAY BEACH, Fla.----XenaCare Holdings, Inc. , a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that is has become a national sponsor of the Arthritis Foundation at the National Proud Sponsor level.

NUTRA PHARMA CORP Financials (EDGAR Online Financials)

Tue, 24 Nov 2009 18:04:51 Etc/GMT

Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution (Business Wire)

Thu, 19 Nov 2009 14:03:00 Etc/GMT

NUTRA PHARMA CORP Files SEC form 8-K/A, Financial Statements and Exhibits (EDGAR Online)

Wed, 18 Nov 2009 21:24:49 Etc/GMT

Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever (Business Wire)

Thu, 12 Nov 2009 14:03:00 Etc/GMT

XenaCare Holdings Announces Availability of Cobroxin through the Chain Drug Marketing Association (CDMA) (Business Wire)

Wed, 4 Nov 2009 13:00:00 Etc/GMT

Rik J. Deitsch, President and CEO of Nutra Pharma, Interviews with The Wall Street Transcript (Wall Street Transcript)

Mon, 2 Nov 2009 19:03:00 Etc/GMT

67 WALL STREET, New York - November 2, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. Included in this 76 page feature is an interview with Rik Deitsch of Nutra Pharma. The full interview is available via The Wall Street Transcript Online.

Nutra Pharma Announces Publication of Research Report by Cohen Independent Research Group (Business Wire)

Thu, 22 Oct 2009 18:48:00 Etc/GMT

XenaCare Holdings Announces Agreement to Market its Over-the-Counter Pain Reliever, Cobroxin, in the Official Annual Publication of NASCAR (Business Wire)

Thu, 22 Oct 2009 13:00:00 Etc/GMT

DELRAY BEACH, Fla.----XenaCare Holdings, Inc. , a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that it has signed an agreement to market its over-the-counter pain reliever, Cobroxin, in Racing One, the official annual publication of NASCAR, for the 2010 racing season.

XenaCare Holdings Announces Agreement to Market OTC Pain Reliever, Cobroxin, in the National Football League (NFL) Alumni Association Publication (Business Wire)

Tue, 20 Oct 2009 13:00:00 Etc/GMT

DELRAY BEACH, Fla.----XenaCare Holdings, Inc. , a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that it has signed an advertising agreement with Belmont International to market its over-the-counter pain reliever, Cobroxin, in the 2009 NFL Alumni Guide and Yearbook.

BUYINS.NET Issues Nutra Pharma SqueezeTrigger Report (GlobeNewswire)

Wed, 14 Oct 2009 17:14:12 Etc/GMT

Nutra Pharma launches drug with cobra venom (at bizjournals.com)

Wed, 14 Oct 2009 16:05:14 Etc/GMT

Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain (Business Wire)

Wed, 14 Oct 2009 13:00:00 Etc/GMT

NUTRA PHARMA CORP Files SEC form 8-K, Unregistered Sale of Equity Securities (EDGAR Online)

Tue, 6 Oct 2009 20:13:47 Etc/GMT

Emerging Stock Report Initiates Independent Research Coverage on Nutra Pharma Corp. (GlobeNewswire)

Fri, 25 Sep 2009 13:30:00 Etc/GMT

Skymark Research Initiates Independent Research Coverage On Nutra Pharma Corp. (GlobeNewswire)

Thu, 10 Sep 2009 12:30:00 Etc/GMT